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ABSTRACT
Rothia mucilaginosa has been found at high abundance on oral leukoplakia (OLK). The ability of
clinical isolates to produce acetaldehyde (ACH) from ethanol has not been investigated. The
objective of the current study was to determine the capacity of R. mucilaginosa isolates recovered
from OLK to generate ACH. Analysis of R. mucilaginosa genomes (n = 70) shows that this species
does not normally encode acetaldehyde dehydrogenase (ALDH) required for detoxification of
ACH. The predicted OLK metagenome also exhibited reduced ALDH coding capacity. We ana-
lysed ACH production in 8 isolates of R. mucilaginosa and showed that this species is capable of
generating ACH in the presence of ethanol. The levels of ACH produced (mean = 53 µM) were
comparable to those produced by Neisseria mucosa and Candida albicans in parallel assays. These
levels were demonstrated to induce oxidative stress in cultured oral keratinocytes. This study
shows that R. mucilaginosa can generate ACH from ethanol in vitro at levels which can induce
oxidative stress. This organism likely contributes to oral ACH levels following alcohol consump-
tion and the significance of the increased abundance of R. mucilaginosa in patients with poten-
tially malignant disorders requires further investigation.
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Introduction
Recent studies have linked changes in the oral micro-
biome with the development of oral cancers, includ-
ing oral squamous cell carcinoma (OSCC) [1,2].
Many hypotheses have been generated to explain
how changes in the oral microbiome could trigger
or exacerbate carcinogenesis [3,4]. Microbial produc-
tion of acetaldehyde (ACH) from ethanol has been
proposed as one such mechanism by which bacteria
could induce mutations in oral keratinocytes [5–7].
Although alcohol consumption is a known risk factor
for OSCC, ethanol itself is not carcinogenic.
However, when alcohol enters the human body, it
can be reduced by host or microbial encoded alcohol
dehydrogenases (ADH) to produce ACH [7]. ACH
has been classified as a carcinogenic substance by the
International Agency for Research on Cancer (IARC)
[8]. It has been shown to have tumorigenic activity in
animal models and exposure of cultured cells to ACH
in vitro results in the generation of DNA adducts and
chromosomal abnormalities [5,9,10]. Studies have
shown that the oral microbiome plays a role in gen-
erating ACH in the oral cavity following alcohol
consumption [5,11]. In vitro studies have shown
that incubation of saliva with ethanol results in the
generation of ACH and that saliva from smokers,
alcohol drinkers and those with poor oral hygiene
generate higher levels of ACH in vitro [11–13].
Patients with OSCC and oral lichenoid disease have
also been shown to harbor acetaldehyde generating
microorganisms at lesional sites, and that cultures
from smokers generated greater levels of acetaldehyde
compared to non-smokers [14].
ACH produced by microorganisms can be further
reduced to acetate by acetaldehyde dehydrogenases
(ALDH). In many bacteria, this ALDH activity is
encoded by the adhE gene, encoding a bifunctional
alcohol and aldehyde dehydrogenase. This enzyme
has been shown to be required for fermentative growth,
efficient use of sugar alcohols and may play a role in
ethanol tolerance in bacteria [15–17]. Fermentative
bacteria that do not express ALDH activity have been
shown to generate high levels of ACH as they do not
have the capacity to detoxify ACH to acetate [18,19].
To date, most studies that have analysed the capacity of
common oral microbes to generate ACH in the pre-
sence of ethanol have implicated Neisseria spp. and
Candida albicans as the most potent producers
[18,20–22]. ACH production by streptococci is strain
specific and is associated with a minority of strains that
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exhibit reduced levels of enzymatic ALDH activity
required to convert ACH to acetate [19,23].
Recently, healthy individuals with a high capacity to
generate ACH in their saliva were found to harbour
a high proportion of Rothia mucilaginosa in the salivary
microbiome [24]. R. mucilaginosa is a Gram-positive,
aerobic, non-spore forming bacterium belonging to the
phylum Actinobacteria [25–27]. R. mucilaginosa is
a member of the healthy oral microbial community
and microbiome studies suggest that this species
accounts for up to 6% of bacteria found on the tongue
[28,29]. Recently, R. mucilaginosa levels have been
shown to be affected by dietary nitrate levels and this
bacterium has been implicated in nitrate reduction in
the oral cavity [30].
Interestingly, our previous analysis of the oral
microbiome in patients with OLK showed that
R. mucilaginosa was more abundant on OLK com-
pared to healthy tissue [29]. We have previously
hypothesised that this increase in R. mucilaginosa
levels could potentially contribute to the malignant
transformation of OLK [31]. In this study, we wished
to investigate this further by determining the capacity
of R. mucilaginosa isolates recovered from patients
with OLK to generate ACH. If this species has a high
capacity to generate ACH, OLK patients may be
exposed to potentially carcinogenic levels of ACH
that could play a role in the development of OLK
and/or malignant transformation of OLK to OSCC.
Material and methods
In silico analysis of oral bacteria genomes
We examined the distribution of predicted ALDH
encoding genes within the genomes of common oral
bacteria using the PATRIC database (https://
patricbrc.org) [32]. The PATRIC database is a large
database of high quality, consistently annotated
microbial genomes. We included 652 complete and
fully annotated bacterial genome sequences repre-
senting the dominant genera of bacteria present in
the oral microbiome. Genes predicted to encode
enzymes with aldehyde dehydrogenase activity (EC
1.2.1.10) were included in our analysis.
Metagenome prediction
PICRUSt can be used to predict gene family abundance
(e.g. the metagenome) in microbial communities for
which only marker gene (e.g. 16S rRNA gene) data are
available [33]. This analysis was carried out on our pre-
viously published microbiome dataset comparing the
microbiomes of oral leukoplakia (OLK) and normal con-
tralateral (NC) healthy tissues from 36 patients [29]. We
have previously shown that the OLK microbiome exhi-
bits increased levels ofR.mucilaginosa and reduced levels
of streptococci compared toNChealthymucosa from the
same patient [29]. Normal contralateral (NC) sites were
deemedhealthy following examinationby an experienced
consultant in oral medicine and acted as an age and oral
hygiene matched control to the diseased sites. The reads
were reclassified with Mothur usingWang’s method and
Greengenes 97% clustered OTUs (version 13.5) as refer-
ence [34]. The reads were then assigned to OTUs based
on their taxonomy (phylotype command) and the gen-
erated file was converted into a BIOM (Biological
Observation Matrix) table. Output files showing the dis-
tribution of genes (catalogued by KEGG ontologies) and
pathway abundances were generated. These files were
analysed using the linear discriminant analysis (LDA)
effect size (LEfSe) method to identify categories enriched
in OLK or healthy NC tissues [35].
Isolation of Rothia mucilaginosa
Mucosal swabs recovered from OLK patients were
cultured on Rothia selective Brain Heart Infusion
(BHI) agar plates. All samples were taken with
informed consent and with approval of the Joint
Hospital’s Research Ethics Committee, Dublin.
Selective BHI agar media consisted of standard
BHI agar supplemented by sodium selenite (Na2
SeO3) at concentration of 50 mg/l and colistin at
concentration 10 mg/l [26]. Bacterial DNA extrac-
tion was carried out as described [36] and PCR
amplification of the 16S gene was carried out
using the primers 27F and 1492R. Following
Sanger DNA sequencing, species identification was
carried out by BLAST analysis of the Human Oral
Microbiome Database (HOMD) and each query
resulted in the identification of R. mucilaginosa as
the best match to the query sequences, with
between 98% and 100% nucleic acid sequence iden-
tity (Table S1).
Growth in ethanol
R. mucilaginosa isolates and several common oral
microbes, including Streptococcus mitis NCTC12261,
Streptococcus gordonii DL1, Neisseria mucosa DSM-
17611 and Candida albicans 132A, were grown in the
presence of ethanol. Strains were incubated in BHI broth
with ethanol at a final concentration (v/v) of 0.0%, 2.0%
(0.44 M) and 4.0% (0.87 M). Growth was measured by
determining theOD600 nmat hourly intervals. Doubling
times were determined from the exponential phase of the
growth curve using Prism 8.3 (GraphPad Software).
Aldehyde detection
Two methods of aldehyde detection were used. Firstly,
a colorimetric aldehyde detection assay kit (Sigma-
Aldrich, Co. Wicklow, Republic of Ireland) was used
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for total aldehyde quantification. Secondly, to verify
these data and to specifically detect ACH, we also
applied solid phase microextraction (SPME) with Gas
chromatography-mass spectrometry (GC-MS) to indi-
cated samples. We analysed 8 strains of R. mucilaginosa
including the reference strain R. mucilaginosa DY-18
(DSM-20746). Several common oral microbes were
included as controls, including Streptococcus mitis
NCTC12261, Streptococcus gordonii DL1, Neisseria
mucosa DSM-17611 and Candida albicans 132A.
Bacteria were grown in BHI broth at 37°C to late
exponential phase (OD600 nm 0.8), harvested by centri-
fugation and washed three times in sterile PBS.
A suspensionmeasuring 0.5 at OD600 nmwas prepared.
A 450 µl volume of this suspension was transferred to
a 2 ml volume plastic screw capped tube (Sarstedt,
Germany) and 50 µl of ethanol solution was added to
yield a final concentration of 10 or 100 mM. After two
hours incubation, the reaction was frozen at −80°C. Total
aldehydes were measured using a colorimetric aldehyde
detection assay kit (Sigma-Aldrich) according to the
manufacturer’s instructions. Samples were incubated
with the detection reagent for 1 h and the coloured
reaction product was measured by determining the
absorbance at 540 nm in a 96-well plate reader (Genios,
Tecan Group Ltd, Switzerland). ACH concentration in
each sample was estimated from a standard curve using
the positive control values from a serial dilution of
a glutaraldehyde standard.
Gas-chromatography mass spectrometry GC-MS was
carried out at the Mass Spectrometry laboratory at
Technological University Dublin (TU Dublin) using
a Varian 3800 gas chromatograph with a Varian Saturn
2000 GC/MS/MS detector. The standard acetaldehyde
solutions (1 µM, 5.0 µM, 100 µM, and 200 µM) were
extracted using a 65 µm PDMS/DVB coated SPME fibre
(Sigma-Aldrich). Prior to each use, the fibre was blanked
and exposed to the headspace of a PTFE-capped 4 ml
glass vial containing 1mLof a 10mg/ml aqueous solution
of O-2,2,4,5,6-(pentafluorobenzyl) hydroxylamine
(PFBHA, 98%; Sigma-Aldrich). The fibre was then
exposed to the ACH standard for 10 min. The PFBHA
formed oxime adducts (cis- and trans- isomers) with the
ACH. The fibre was then inserted into the injection port
of the GC-MS and left to desorb for 2min. For analysis of
the bacterial samples, a blanked fibre was first exposed to
PFBHA for 10 min, then the fibre was exposed to the
headspace of the reaction samples for 10 min. The fibre
was then desorbed in the injection port for 2 min and the
analysis was left to run. Any ACH present in the samples
then formed the same oxime adducts as previously
mentioned.
Measurement of ACH induced ROS production
In order to determine whether ACH (25–100 µM; cor-
responding to the levels produced by R. mucilaginosa
in vitro) could induce stress in oral keratinocytes, we
exposed cultured TR146 keratinocytes to ACH in vitro.
Oral keratinocytes were cultured as described by
Connolly et al. [37]. Tomeasure reactive oxygen species
(ROS) production, 2ʹ,7ʹDichlorodihydrofluorescein dia-
cetate (DCF-DA; Sigma Aldrich) was used, which is
non-fluorescent unless oxidized by intracellular ROS.
TR146 cells were incubated with 100 µM DCF-DA in
96-well plates for 1 h at 37°C. Measurement of intracel-
lular ROS was performed by incubating TR146 cells
with either serum-free medium containing ACH (25,
50, 75, 100 µM) for 3 h with or without 1 h pretreatment
with 100 µM of the antioxidant N-acetylcysteine
(NAC). H2O2 (30 mM) was used as a positive control
and PBS was added as a negative control. Cells were
then washed two times in Hank’s balanced salt solution
buffer (HBSS) and the fluorescence (485 nm excitation/
530 nm emission) was measured using a Tecan plate-
reader (Genios, Tecan). The effect of ACH at these
levels was also examined using a fluorescence micro-
scope (Zeiss Instruments). DCF-DA fluorescence was
visualized with a GFP filter set (485 nm excitation/
530 nm emission) andHoechst stained nuclei visualized
with a standard DAPI filter set.
Results
Acetaldehyde dehydrogenase genes in oral
bacteria
Weexamined the distribution of predictedALDHencod-
ing genes in 652 complete and fully annotated oral bac-
terial genome sequences (Figure 1(a)). A total of 260
streptococcal genomes were analysed and these were
found to contain 479 putative ALDH encoding genes,
with 99% of genomes harbouring at least 1 gene.
Genomes of Bacteroidetes (Porphyromonas spp.,
Tannerella spp. and Prevotella spp.) did not contain any
predicted ALDH genes. Other than Bacteroidetes, the
Actinobacteria, including Actinomyces spp. and Rothia
spp., had the lowest percentages of predicted ALDH
encoding genes (7% and 3%, respectively; Figure 1(a)).
Of the 70 Rothia spp. genomes analysed, only two
strains encoded geneswith homology toALDHencoding
genes. R. mucilaginosa strain 204_RMUC harboured
a gene encoding a protein with 100% identity to
a protein in S. oralis strain Uo5 (adhE, PATRIC ID: fig|
927666.3.peg.160). Secondly, R. mucilaginosa strain
382_RMUC contained a gene encoding a protein with
100% identity to an ALDH encoding gene fromNeisseria
mucosa ATCC 25996 (PATRIC ID: fig|546266.6.
peg.2301). Alignment of these loci identified flanking
regions of homology to S. oralis andN.mucosa suggesting
that two strains acquired these genes during recent hor-
izontal gene transfer events (Figure S1). BLAST analysis
of both proteins from R. mucilaginosa strains
382_RMUC and strain 204_RMUC against the
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remaining 68 Rothia genomes did not identify any addi-
tional putative ALDH enzymes.
Oral leukoplakia metagenome has reduced ALDH
coding capacity
We next applied the metagenome prediction tool
PICRUSt to our previously published 16S rRNA
analysis of the microbiome of OLK and healthy NC
mucosal samples from 36 patients [29]. Using LEfSe
analysis (Figure S2), we observed increased levels of
genes encoding acetaldehyde dehydrogenases
(K04072) in NC healthy tissue compared to OLK
samples (P = 0.008; Figure 1(b)). There was no sig-
nificant difference between OLKs exhibiting different
degrees of dysplasia. Examination of the pathway
Figure 1. (a) Graphic representation of ALDH coding capacity in different taxonomic groups of oral bacteria, investigated using the
PATRIC database. The percentage of strains with a predicted ALDH encoding gene is indicated and highlighted in red. Other Firmicutes
includes Granulicatella spp. (n = 6) and Gemella spp. (n = 4). Fusobacteria includes Fusobacterium spp. (n = 15) and Leptotrichia spp.
(n = 15). Bacteroidetes includes Porphyromonas spp. (n = 71), Prevotella spp, (n = 66) and Tannerella spp. (n = 3). (b) Plot generated in
LEfSe showing the increased abundance of acetaldehyde dehydrogenase enzyme (EC 1.2.1.10) encoding genes in the metagenomes of
samples from healthy NC mucosa compared to OLK (P = 0.008). OLK are categorized as in mild to moderate dysplasia (red) and severe
dysplasia (green). Straight and dotted lines correspond to mean and median values, respectively.
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level data showed that OLK samples exhibited enrich-
ment for genes involved in lipopolysaccharide bio-
synthesis compared to the NC samples (Figure S3).
Carbohydrate metabolism was generally more preva-
lent in NC tissues (Figure S3).
Growth and ACH production by R. mucilaginosa
in the presence of ethanol
Next, we determined if lack of ALDH affected the
susceptibility of R. mucilaginosa to high concentrations
of ethanol in comparison to other common oral
microbes (Figure 2). In general, all bacteria were
severely inhibited by 4% ethanol, whereas C. albicans
132A was still capable of growth following a short lag
period (Figure 2). At 2% ethanol, R. mucilaginosa and
Neisseria mucosa exhibited reduced growth (Figure 2)
and longer doubling times (Table S2) whereas S. mitis
and S. gordonii were largely unaffected by growth in 2%
ethanol (Figure 2; Table S2).
Next, a colorimetric assaywas carried out todetermine
the level of aldehydes produced by R. mucilaginosa
in vitro in the absence and presence of subinhibitory
concentrations ethanol (10 mM and 100 mM). Known
ACH producing species C. albicans 132A and N. mucosa
DSM17611 yielded on average approximately 53 µM and
100 µM aldehyde in the presence of 100 mM ethanol,
respectively (Figure 3(a)). Aldehyde levels in S. gordonii
DL1were undetectable and S. mitisNCTC1226 yielded ~
10 µM (Figure 3(a)). The type strain of R. mucilaginosa,
DY18, yielded approximately 40 µM aldehyde under the
same conditions (Figure 3(a)). Analysis of the 7 addi-
tional clinical isolates of R. mucilaginosa indicated an
average yield of 53 µM aldehyde (Figure 3(b)). Most
isolates (6/8) produced 40–60 µM with the exception of
40A1 which was consistently lower (10 µM) and 41C2,
which consistently produced the highest levels of alde-
hyde observed here at approximately 180 µM (Figure
3(b)).
Solid phase microextraction (SPME) with Gas chro-
matography-mass spectrometry (GC-MS) was used to
specifically measure ACH levels in additional experi-
ments, confirming that the data from colorimetric mea-
surements corresponded to ACH production. These
analyses confirmed the production of approximately
150 µM and 80 µM ACH in strains R. mucilaginosa
41C2 and 66A9 respectively (Figure 3(c))
Effect of ACH on oxidative stress levels in oral
keratinocytes
After measuring the level of ACH produced by
R. mucilaginosa strains, we examined whether these
levels were capable of inducing oxidative stress in
Figure 2. Growth of oral bacteria in BHI at 37°C in the presence of ethanol (0%, 2% and 4% v/v). Plots are the results of three
separate replicate experiments.
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TR146 oral keratinocytes. Increasing levels of ACH (25
to 75 µM) resulted in increased DCF-DA fluorescence
(Figure 4(a)). The addition of the antioxidant NAC
reduced the level of ROS induced fluorescence (Figure
4(a)). Interestingly, the highest concentration of ACH
did not yield significantly higher levels of fluorescence,
which may be due to cell toxicity or death.
The effect of ACH at these levels was also exam-
ined using fluorescence microscopy. The addition of
ACH (50 or 100 µM) or H2O2 (30 mM) resulted in
bright green fluorescence, which could be reduced by
the addition of NAC (Figure 4(b)).
Discussion
We recently investigated the microbiome associated
with OLK, a potentially malignant lesion with the
potential to transform to OSCC. Unexpectedly,
these studies identified increased levels of
R. mucilaginosa on OLK. This was surprising as pre-
vious studies of OSCC have shown that the abun-
dance R. mucilaginosa is decreased at oral cancers
[1,38]. Although R. mucilaginosa is generally absent
or reduced at OSCCs, our data do not preclude the
possibility that the increased abundance of this
organism on OLK could play a role in the malignant
transformation to OSCC through the production of
toxic metabolites such as ACH. The predictive meta-
genome (PICRUSt) analysis presented here showed
that bacterial communities found on OLK have sig-
nificantly fewer genes encoding ALDH compared to
healthy mucosa. This reduced expression of ALDH
enzymes, which are required to metabolise ACH,
would reduce the capacity of these OLK communities
to remove toxic and carcinogenic ACH from the
vicinity of the oral mucosa. Our analysis of oral
bacterial genomes indicate that this change in the
OLK metagenome is likely due to the decreased
abundance of streptococci (which generally encode
ALDH) and the increased abundance of
R. mucilaginosa (which generally do not encode
ALDH) on OLK. Our analysis of the 70 genomes
corresponding to Rothia spp. in the PATRIC database
showed that only two genes encoding ALDHs were
present in this group of strains. The genes were pre-
sent in two strains of R. mucilaginosa recovered from
bronchoalveolar lavage specimens from intensive care
patients [39] and the genes present are likely the
result of recent horizontal gene transfer events.
None of the oral isolates examined encoded ALDH.
Interestingly, a high proportion (69%) of strains of
Neisseria spp. harboured a predicted ALDH encoding
gene. Previous studies have shown that oral strains of
Neisseria lack enzymatic ALDH activity and generate
high levels of ACH, demonstrating that in Neisseria
spp., possession of an ALDH encoding gene does not
necessarily translate to high levels of enzymatic
ALDH activity [18].
Figure 3. (a) Aldehyde production by representative oral microorganisms in the presence of 10 mM and 100 mM ethanol.
Aldehyde was detected using a colorimetric assay. Data is the average of three separate experiments. Red asterisk indicates
different axis scale. (b) Aldehyde production by clinical isolates of R. mucilaginosa in the presence of 100 mM ethanol. Red:
>100 µM; Orange: 30–100 µM; yellow: < 20 µM. (c) Comparison of aldehyde and acetaldehyde measurements by colorimetric
and GC-MS analysis following incubation of strains in 100 mM ethanol.
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Next, we decided to isolate R mucilaginosa from
OLK patients to determine their capacity to generate
ACH from ethanol. We initially used a colorimetric
assay which detects total aldehyde production.
Under the assay conditions, this method produced
very similar results to GC-MS analysis for acetalde-
hyde using representative strains (Figure 3(b)).
Previous studies with oral streptococci and
Neisseria spp. have shown that bacteria that lack
ALDH activity have increased capacity to generate
ACH in the presence of ethanol. Our analysis of 8
R. mucilaginosa strains here shows that, in the pre-
sence of 100 mM ethanol, most of the isolates (6/8)
produced acetaldehyde in the range of 40–60 µM,
with one isolate (41C2) generating on average
>150 µM ACH detected by GC-MS. These ACH
levels were similar to, or in the case of isolate
41C2, in excess of those detected with isolates of
N. mucosa and C. albicans, microbes previously
implicated as the primary sources of microbial
ACH in the oral cavity. All of these R. mucilaginosa
isolates were recovered from patients with a history
of alcohol consumption placing them at risk of ACH
exposure (Table S1). The absence of an ALDH
encoding gene has also been associated with
increased susceptibility to ethanol in bacteria [15].
All bacteria here were inhibited in the presence of
4% (~0.87 M) ethanol. The ALDH positive strepto-
cocci were unaffected by the presence of 2%
(~0.44 M) ethanol whereas the acetaldehyde produ-
cers (Rothia, Neisseria) exhibited increased suscept-
ibility to growth inhibition by 2% ethanol.
These studies demonstrate that R. mucilaginosa,
an important component of the normal oral micro-
biome can produce ACH. Recently, Yokoyama et al.
(2018) showed that individuals with the highest
Figure 4. (a) Showing ACH induced oxidative stress in TR146 oral keratinocytes. Cells were incubated with ACH (25 µM –
100 µM) in 96 well plates. 30 mM H2O2 was used as positive control and medium containing PBS as a negative control. Reactive
oxygen species (ROS) were detected by measuring DCF-DA fluorescence in a microplate reader (Genios, Tecan) in the presence
and absence of N-acetylcysteine (NAC). Results are the average of three separate experiments. (b) Showing fluorescence in
TR146 cells stained with DCF-DA to detect ROS (green) and Hoechst to detect nuclei (blue). Cells were preincubated in 100 µM
of DCF-DA with or without NAC. Cells were then exposed to stress (50 or 100 µM ACH or 30 mM H2O2) and visualized using
a Zeiss epifluorescence microscope.
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capacity to generate ACH in saliva had increased
levels of R. mucilaginosa and S. salivarius in their
salivary microbiome [24]. Our data would support
a direct role for R. mucilaginosa in generating ACH
in those individuals. Our previous studies of the
microbiome of OLK identified higher levels of
R. mucilaginosa on OLK relative to healthy NC
tissue from the same patients. This species shift
reduces ALDH functionality in the metagenome
which could lead to local build-up of ACH at the
site of the OLK. If this hypothesis is true, local ACH
production may contribute to the malignant trans-
formation of these lesions. Alternatively, the species
shift may have predated the OLK and contributed
to the development of the OLK itself. This study
indicates that the levels of ACH produced by
R. mucilaginosa are capable of inducing oxidative
stress in oral keratinocytes, indicating that this level
of ACH production is biologically significant. The
ACH levels detected in these experiments are simi-
lar to the concentrations that can be detected in the
oral cavity after alcohol consumption [13].
In conclusion, our earlier work has demonstrated
increased prevalence of R. mucilaginosa in patients
at OLK sites compared to at contralateral normal
sites. This current study provides further evidence
to implicate R. mucilaginosa in the pathogenesis of
OLK. Its presence is likely to lead to increased ACH
production in the oral cavity which could be
involved in the development of OLK ab initio and/
or the malignant transformation of these lesions,
especially in those patients who drink alcohol.
R. mucilaginosa requires further investigation as
a contributor to the oral ACH burden following
alcohol consumption. If this can be confirmed, stra-
tegies to control R. mucilaginosa could be useful in
preventing the development of OLK in those who
drink alcohol and/or reducing the malignant trans-
formation of OLK to OSCC.
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